<\/p>\n
Rivamer<\/strong> is an oral capsule from Sun Pharma containing rivastigmine 1.5 mg<\/strong> — a dual acetylcholinesterase + butyrylcholinesterase inhibitor<\/strong> anvendes til den symptomatiske behandling af mild til moderat Alzheimers sygdom<\/strong> AND Parkinsons sygdom med demens<\/strong> (the only AChE inhibitor licensed for PDD). Slow titration: 1.5 mg twice daily for 2 weeks → 3 mg twice daily for 2 weeks → 4.5 mg twice daily for 2 weeks → 6 mg twice daily maintenance<\/strong>. Always take with food.<\/strong> The transdermal patch (not stocked here) significantly reduces GI side effects and is preferred for patients who cannot tolerate the oral form.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomsp\u00e6ndende i diskret, neutral emballage \u2014 ingen medicinnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller medicinnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n Rivamer is an oral capsule from Sun Pharma containing rivastigmine tartrate 1.5 mg<\/strong>. Rivastigmine is a pseudo-irreversible dual cholinesterase inhibitor<\/strong> — it inhibits both acetylcholinesterase (AChE)<\/strong> og butyrylcholinesterase (BuChE)<\/strong>. The dual mechanism distinguishes it from donepezil and galantamine, which only inhibit AChE.<\/p>\n Rivamer from Sun Pharma is a 1.5 mg rivastigmine capsule — the starting dose for the 6–8 week titration in mild-to-moderate Alzheimer's and Parkinson's disease dementia. Titrate to the maintenance 12 mg\/day dose. Always take with food to minimise the GI side effects that are characteristic of oral rivastigmine. Rivastigmine is the only cholinesterase inhibitor with a licensed indication for Parkinsons sygdom med demens<\/strong> in addition to mild-to-moderate Alzheimer's. The dual ACh + BuChE inhibition may matter more in PDD because BuChE activity is relatively preserved in PD compared with Alzheimer's.<\/p>\n Both Alzheimer's disease and Parkinson's disease dementia involve cholinergic neuron loss. Rivastigmine raises synaptic acetylcholine through dual enzymatic inhibition:<\/p>\n Inds\u00e6ttelse af kognitiv forbedring: synlig ved 6\u201312 uger<\/strong> on the maintenance 9–12 mg\/day dose; peak at 6 months.<\/p>\n Rivamer is ikke<\/strong> indicated for: severe Alzheimer's disease (only donepezil is licensed at this stage), mild cognitive impairment, frontotemporal dementia (worsens behavioural symptoms), or as a cognitive enhancer in healthy adults.<\/p>\n Rivamer comes at 1,5 mg<\/strong> capsules. The 6–8 week titration is mandatory — rivastigmine has the most aggressive GI profile of all AChE inhibitors when given orally.<\/p>\n Standard 6–8 week titration:<\/strong><\/p>\n Common (highest GI burden of all oral AChE inhibitors):<\/strong><\/p>\n Mindre almindelige, men vigtige:<\/strong><\/p>\n Sj\u00e6ldne, men s\u00f8g l\u00e6gehj\u00e6lp:<\/strong><\/p>\nHvorfor bestille fra MedsBase<\/h3>\n
What Is Rivamer?<\/h2>\n
How Does Rivamer Work?<\/h2>\n
\n
\u2014 det forst\u00e6rker den normale fysiologiske respons snarere end at udl\u00f8se en kunstigt.<\/h2>\n
\n
Rivamer Dosage and How to Take — SLOW TITRATION<\/h2>\n
\n
How to Take Rivamer Properly<\/h3>\n
\n
Side Effects of Rivamer<\/h2>\n
\n
\n
\n
Advarsler og forholdsregler<\/h2>\n
\n
Contraindications — Who Should NOT Take Rivamer<\/h2>\n
\n
L\u00e6gemiddelinteraktioner<\/h2>\n